C4 glomerulopathy other diagnostic studies

Jump to navigation Jump to search

C4 glomerulopathy Microchapters

Complement Mediated Glomerular Disorders Main Page

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating C4 glomerulopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Studies

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

C4 glomerulopathy other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of C4 glomerulopathy other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on C4 glomerulopathy other diagnostic studies

CDC on C4 glomerulopathy other diagnostic studies

C4 glomerulopathy other diagnostic studies in the news

Blogs on C4 glomerulopathy other diagnostic studies

Directions to Hospitals Treating C4 glomerulopathy

Risk calculators and risk factors for C4 glomerulopathy other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Ali Poyan Mehr, M.D. [2]; Associate Editor(s)-in-Chief: Olufunmilola Olubukola M.D.[3]

Overview

Other Diagnostic Studies

A kidney biopsy may be helpful in the diagnosis of C4 glomerulopathy. Findings suggestive of C4 glomerulopathy include[1][2][3][4][5]:

  • Membranoproliferative glomerulonephritis, with mesangial and endocapillary hypercellularity.
  • The glomerular capillary walls thickening.
  • Periodic acid–Schiff stain finding of ribbonlike material on the glomerular basement membrane.
  • Immunofluorescence microscopy indicates no glomerular staining for IgA, IgM, IgG, C3, C1q, kappa or lambda light chains.
  • Electron microscopy is favorable for large subendothelial osmiophilic dense deposits lining the glomerular basement membrane.
  • C4d glomerular staining help as a marker for immune complex-mediated glomerulonephritis.
  • Positive C4d can also assist as a marker for glomerulopathy resulting from activation of the Lectin pathway.

References

  1. Sethi S, Fervenza FC (2012). "Membranoproliferative glomerulonephritis--a new look at an old entity". N Engl J Med. 366 (12): 1119–31. doi:10.1056/NEJMra1108178. PMID 22435371.
  2. Zhang Y, Meyer NC, Wang K, Nishimura C, Frees K, Jones M; et al. (2012). "Causes of alternative pathway dysregulation in dense deposit disease". Clin J Am Soc Nephrol. 7 (2): 265–74. doi:10.2215/CJN.07900811. PMC 3280037. PMID 22223606.
  3. Sahin OZ, Gurses S, Taslı F, Yavas H, Ersoy R, Uzum A; et al. (2013). "Glomerular c4d staining can be an indicator of disease activity in lupus nephritis". Ren Fail. 35 (2): 222–5. doi:10.3109/0886022X.2012.743916. PMID 23176021.
  4. Espinosa M, Ortega R, Sánchez M, Segarra A, Salcedo MT, González F; et al. (2014). "Association of C4d deposition with clinical outcomes in IgA nephropathy". Clin J Am Soc Nephrol. 9 (5): 897–904. doi:10.2215/CJN.09710913. PMC 4011455. PMID 24578331.
  5. Sethi S, Nasr SH, De Vriese AS, Fervenza FC (2015). "C4d as a Diagnostic Tool in Proliferative GN". J Am Soc Nephrol. 26 (11): 2852–9. doi:10.1681/ASN.2014040406. PMC 4625660. PMID 25991041.

Template:WHTemplate:WS